Does sildenafil cause blood clots? This is a common concern for men prescribed this medication for erectile dysfunction or pulmonary arterial hypertension. Sildenafil, widely known as Viagra, is a phosphodiesterase type 5 (PDE5) inhibitor with no established causal link to blood clots. Extensive clinical trials and post-marketing surveillance have not identified thromboembolism as a recognised adverse effect. However, patients taking sildenafil may have underlying cardiovascular risk factors that independently increase clotting risk. This article examines the evidence, explains how sildenafil works, and clarifies when to seek medical advice whilst taking this medication.

Does Sildenafil Cause Blood Clots?

There is no established causal link between sildenafil and blood clots. Sildenafil (commonly known by the brand name Viagra) is a phosphodiesterase type 5 (PDE5) inhibitor primarily prescribed for erectile dysfunction and pulmonary arterial hypertension. Extensive clinical trials and post-marketing surveillance data have not identified blood clots (thromboembolism) as a recognised adverse effect of this medication, as confirmed by the Medicines and Healthcare products Regulatory Agency (MHRA) in the sildenafil Summary of Product Characteristics.

Some laboratory studies (in vitro and ex vivo) have suggested sildenafil may have antiplatelet properties that could theoretically affect platelet aggregation, though this has not translated into proven clinical benefits for reducing clotting risk. The clinical significance of these laboratory findings remains uncertain and under investigation.

It is important to distinguish between direct causation and coincidental occurrence. Men seeking treatment for erectile dysfunction may have underlying cardiovascular risk factors—such as diabetes, hypertension, obesity, or atherosclerosis—that independently increase their risk of developing blood clots. The presence of these comorbidities, rather than sildenafil itself, may explain any thrombotic events that occur in patients taking the medication. Rare serious cardiovascular events have been reported post-marketing in temporal association with sildenafil use, though causality has not been established.

If you have concerns about blood clots whilst taking sildenafil, discuss your individual risk factors with your GP or prescribing clinician. They can assess your cardiovascular health comprehensively and determine whether sildenafil remains appropriate for your circumstances. Never discontinue prescribed medication without medical guidance.

Blood Clot Symptoms to Watch For

Whilst sildenafil does not cause blood clots, it remains essential to recognise the warning signs of thromboembolism, particularly if you have pre-existing risk factors. Blood clots can occur in different parts of the body, producing distinct symptoms that require medical attention.

Deep vein thrombosis (DVT), typically affecting the legs, may present with:

• Swelling in one leg (rarely both)

• Pain or tenderness, often starting in the calf

• Warm skin in the affected area

• Red or discoloured skin

• Pain when standing or walking

Pulmonary embolism (PE) occurs when a clot travels to the lungs and represents a medical emergency. Symptoms include:

• Sudden breathlessness or difficulty breathing

• Sharp chest pain that worsens with deep breathing or coughing

• Coughing up blood (haemoptysis)

• Rapid heart rate or palpitations

• Feeling lightheaded or fainting

Arterial thrombosis affecting other areas may cause stroke symptoms (facial drooping, arm weakness, speech difficulties) or signs of heart attack (central chest pain, pain radiating to the jaw or arm, nausea, sweating).

These symptoms can develop suddenly or gradually over hours to days. If you suspect a pulmonary embolism, stroke or heart attack, call 999 immediately. For suspected DVT without breathing problems or chest pain, contact your GP urgently or call NHS 111 for same-day assessment. Risk factors for blood clots include previous DVT/PE, prolonged immobility, recent surgery, cancer, smoking, obesity, pregnancy, thrombophilia (inherited clotting disorders), and oestrogen therapy. If you have multiple risk factors, discuss preventative strategies with your healthcare provider.

When to Seek Medical Advice About Sildenafil

Understanding when to contact your GP or seek emergency care whilst taking sildenafil is crucial for your safety. Seek immediate emergency care (call 999 or attend A&E) if you experience:

• Chest pain or pressure, particularly if severe or radiating to your arm, jaw, or back

• Sudden severe breathlessness or difficulty breathing

• Signs of stroke (facial drooping, arm weakness, slurred speech)

• Symptoms suggestive of pulmonary embolism as described in the previous section

• An erection lasting longer than four hours (priapism)

• Sudden vision or hearing loss

These symptoms require urgent assessment regardless of any perceived connection to sildenafil.

Contact your GP urgently or call NHS 111 for same-day assessment if you have:

• Symptoms suggestive of DVT (leg swelling, pain, warmth, redness) without breathing problems

Contact your GP or prescribing clinician within 24-48 hours if you experience:

• New or worsening headaches whilst taking sildenafil

• Persistent indigestion or heartburn

• Dizziness or lightheadedness that affects daily activities

• Flushing or skin reactions that concern you

• Any side effects that interfere with your quality of life

Schedule a routine appointment to discuss:

• Changes in your cardiovascular health or new diagnoses

• Starting new medications that might interact with sildenafil

• Reduced effectiveness of sildenafil over time

• Questions about appropriate dosing or timing

Sildenafil must not be taken with nitrate medications (e.g., GTN spray, isosorbide mononitrate) or riociguat, as this can cause dangerous drops in blood pressure. Use with caution alongside alpha-blockers, and be aware that strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole, ritonavir) and grapefruit juice can increase sildenafil levels.

Your prescriber should conduct regular medication reviews, particularly if you have cardiovascular disease, diabetes, or other chronic conditions. NICE guidance recommends that men with erectile dysfunction receive holistic cardiovascular risk assessment, as erectile dysfunction can be an early marker of systemic vascular disease. Never obtain sildenafil from unregulated sources, as counterfeit medications may contain harmful substances or incorrect doses. Always use medications prescribed specifically for you by a registered healthcare professional.

If you suspect an adverse reaction to sildenafil, you can report it through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app).

How Sildenafil Works in Your Body

Understanding sildenafil's mechanism of action helps clarify why it does not cause blood clots and how it produces its therapeutic effects. Sildenafil belongs to a class of medications called phosphodiesterase type 5 (PDE5) inhibitors. These drugs work by blocking the enzyme PDE5, which is found in high concentrations in the smooth muscle of blood vessels supplying the penis and lungs, though it is present in other tissues as well.

During sexual arousal, nerve signals trigger the release of nitric oxide in penile tissue. Nitric oxide activates an enzyme that produces cyclic guanosine monophosphate (cGMP), a chemical messenger that relaxes smooth muscle and allows blood vessels to dilate. Sildenafil enhances this natural process by preventing PDE5 from breaking down cGMP, thereby prolonging smooth muscle relaxation and improving blood flow to the penis, facilitating an erection in response to sexual stimulation.

Crucially, sildenafil does not work without sexual arousal—it amplifies the body's natural erectile response rather than creating an artificial one. The medication is absorbed within 30-60 minutes of oral administration, reaches peak plasma concentrations after approximately one hour (though a high-fat meal can delay absorption and reduce maximum concentration), and has a half-life of 3-5 hours. It is metabolised primarily in the liver by cytochrome P450 enzymes, mainly CYP3A4 with a minor contribution from CYP2C9.

In pulmonary arterial hypertension, sildenafil's ability to dilate blood vessels reduces pressure in the pulmonary arteries, improving exercise capacity and symptoms. The medication's effects are more pronounced in tissues with high PDE5 concentrations and there is no evidence that sildenafil is pro-thrombotic. While laboratory studies have shown possible inhibition of platelet aggregation, this has not translated into proven clinical benefits for reducing clot risk. This pharmacological profile explains why sildenafil is not associated with increased blood clot risk when used as prescribed.

Frequently Asked Questions